AURORA CANNABIS INC
ACBNASDAQTrading Snapshot
- Day Range
- $4.02 – $4.06
- 52-Week Range
- $2.56 – $6.67
- Volume
- $3.71B
- Avg Volume
- $4.10B
- Shares Outstanding
- 61.9M
- Next Earnings
- Oct 25, 2026
Fundamentals Snapshot
- Annual Revenue
- $321M
- Last Q Revenue
- $68M
- P/E Ratio
- -3.0
- P/S Ratio
- 1.2x
- EPS (TTM)
- $-1.80
- Dividend Yield
- 0.00%
- Dilution (1yr)
- +7.6%
Why Investors Own ACB
- ✓High-growth profile — revenue up +1.3% YoY with expanding US Equity exposure.
- ✓Healthy economics — 34% gross margin and 23% free-cash-flow margin.
- ✓New products and segments could unlock additional revenue streams.
Execution delays, intensifying competition, and valuation compression if growth decelerates.
AURORA CANNABIS INC
ACB
StockOtter · stockotter.spaceAbout AURORA CANNABIS INC
Aurora Cannabis Inc. is a leading company in the global cannabis industry, focusing on the cultivation, production, and sale of various cannabis and cannabis-derived products across Canada and internationally. Beyond its core product offerings, the company engages in a broad spectrum of related activities, including the design and engineering of facilities, cannabis breeding programs, research and development, and both wholesale and retail distribution channels. For medical users, Aurora provides a diverse selection of products such as different strains of dried cannabis, cannabis oils, capsules, and topical kits. Their inventory also includes ancillary items like vaporizers, vaporizer accessories, herb mills (specifically for CanniMed products), grinders, and secure containers for vaporizers. The company is actively involved in developing advanced medical cannabis products, with ongoing work on oral, topical, edible, and inhalable formulations. Furthermore, Aurora manages CanvasRX, a network of centers dedicated to cannabis counseling and community outreach. Its service portfolio extends to providing patient support, specialized design and construction services, and comprehensive analytical testing for cannabis products. Aurora Cannabis Inc. manages an extensive collection of brands, including Aurora, Aurora Drift, San Rafael '71, Daily Special, AltaVie, MedReleaf, CanniMed, Whistler, Woodstock, and WMMC. The company's main corporate office is located in Edmonton, Canada.
Otter Score Breakdown
How it's scoredFive components, each rated 1–5★ and equally weighted (20%), averaged to a 0–100 score:💎 Quality — gross margin🚀 Growth — revenue YoY⚖️ Valuation — P/S ratio⚡ Momentum — 30-day price change💧 Dilution — 1-yr share issuance (buybacks score higher)Analyst Price Target
ⓘLatest News & Updates
Curaleaf's Hostile Takeover Attempt of Aurora Cannabis Is Hitting Turbulence. Here's What Investors Should Watch.
Curaleaf presented an unsolicited offer to buy Aurora Cannabis for $4 per share. Aurora rejected the offer, saying it didn't fully value Aurora's business.
Aurora Cannabis Files Application with Alberta Securities Commission to Protect Company Shareholders Having Identified Several Deficiencies in Curaleaf's Hostile Bid Disclosure
NASDAQ | TSX: ACB Aurora has filed an application with the Alberta Securities Commission for an order requiring Curaleaf to comply with securities laws. Aurora intends to demonstrate that Curaleaf's Circular has not sati
Aurora Cannabis Provides Business Update; Accretive Acquisition of Safari Flower Company and Leading European Performance Expected to Fuel International Growth in the Fiscal Second Quarter 2027 and Beyond
NASDAQ| TSX: ACB Re-affirms FY27 Q2 guidance for sequential growth in quarterly net revenue and adjusted EBITDA 1 Following the receipt of EU-GMP certification in July, Safari Flower Company is expected to contribute inc
Curaleaf Tries To Roll Up Aurora In a Hostile Cannabis Bid
Cross-border consolidation in the cannabis industry has moved from executive speculation into aggressive dealmaking. As regulatory hurdles begin to clear across North America and Europe, operators are moving quickly to s
Aurora Cannabis Refutes Curaleaf's Latest Attempt To Distract Shareholders From The Facts
Aurora Cannabis Refutes Curaleaf's Latest Attempt To Distract Shareholders From The FactsPR NewswireEDMONTON, AB, Sept. 14, 2026NASDAQ | TSX: ACBCuraleaf's anno
$250,000 in These 3 High-Income ETFs Could Pay You ~$2,800 a Month
Options-income ETFs now offer monthly payouts that dwarf what traditional dividend stocks provide, but before you move a dollar, there are tax mechanics and capital preservation risks that most income investors completel